Assessment of Pancreatitis with Hyperbilirubinemia

Initial Diagnostic Approach

In patients with pancreatitis and hyperbilirubinemia, immediately obtain liver chemistries at admission, as elevated aminotransferases or bilirubin strongly suggest a gallstone etiology and guide urgent management decisions 1, 2
The American College of Gastroenterology recommends measuring serum aminotransferases (AST, ALT) within the first 48 hours, as elevations suggest biliary pancreatitis and predict the need for biliary intervention 3
Obtain total and direct (conjugated) bilirubin levels to differentiate between hepatocellular disease, cholestatic obstruction, or metabolic causes 4
Check serum lipase (>3 times upper limit of normal) to confirm pancreatitis diagnosis 2
Measure serum calcium to identify hypercalcemia as a potential cause 1

All patients require severity assessment using APACHE II score (cutoff >8) or Glasgow score, with C-reactive protein measured at 48 hours (>150 mg/L indicates severe disease) 1, 2
Patients with APACHE II score >8, persistent organ failure, or hematocrit >44% and urea >20 mg/dL require ICU/intermediate care unit triage 2
Perform contrast-enhanced CT scan after 72 hours (not before) in patients with predicted severe disease to assess pancreatic necrosis—early CT underestimates necrosis extent 1, 2

For mild gallstone pancreatitis, perform cholecystectomy during the same hospital admission, ideally within two weeks and no longer than four weeks, to prevent recurrent pancreatitis 6
For severe pancreatitis with persistent bile duct obstruction, if persistent extrahepatic obstruction is due to inflammatory pancreatic tissue compression, choledochoduodenostomy is the procedure of choice 6
The American College of Surgeons recommends searching for common bile duct stones during cholecystectomy and treating during the same procedure if local conditions are adequate 6

All patients require daily or more frequent reassessment to detect life-threatening complications early 6
Monitor leucocyte and platelet counts, clotting parameters, APACHE II score, and CRP concentration 6
Repeat dynamic CT every two weeks in severe pancreatitis, more frequently if sepsis or adverse clinical features develop 6

Do not accept "idiopathic" pancreatitis without thorough investigation—etiology should be established in 75-80% of cases through repeated ultrasounds, MRCP, or EUS 1, 2, 5
Never perform CT before 72 hours for severity assessment, as it underestimates necrosis extent 1
Avoid routine ERCP in patients with single mild attack without jaundice or bile duct dilation, as the procedure carries complication risks 5